Adaptation of Pediatric Speech Audiometry Tests Into Other Languages
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2-7
SponsorSemmelweis University
About this trial
The objective of this study was to offer a comprehensive framework for the adaptation of speech audiometric tests into other languages. To date, this is the first universal protocol of its kind that systematically considers linguistic, phonological, and audiological aspects.
The present paper provides a protocol and an example for adaptation and standardization of the Mainzer Audiometric Test for Children (MATCH) to another language.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age: limits for age groups: 2-4,5; 4,5-5,5; 5,5-7, respectively.
For control goups: normal hearing verified by pure tone audiometry and tympanometry
For hearing-impairment groups: stable sensorineural hearing loss confirmed by audiological diagnostics
Disqualifiers
Children presenting with symptoms of upper respiratory tract infections
Known speech-language developmental disorders
Cognitive disorders
Trial population
Children aged 2-7, with normal hearing in case of control groups and with stable sensorineural hearing loss in case of hearing-impairment groups.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
120 Participants
are grouped into 6 trial groups6
Trial groupsSee each trial group below.
Group A: Group 1 N
Group B: Group 2 N
Group C: Group 3 N
Group D: Group 1 P
Group E: Group 2 P
Group F: Group 3 P
Trial outcomes
Primary outcomes
1
Correlation between SRTs obtained with the adapted MATCH and the PTA thresholds (500 Hz, 1, 2, and 4 kHz)
The primary outcome measure is the correlation between Speech Recognition thresholds obtained with the adapted MATCH and the Pure Tone Audiometry thresholds (500 Hz, 1, 2, and 4 kHz).
Time frame
Through study completion, an average of 1 year.Secondary outcomes
1
Test-retest reliability (intraclass correlation coefficients, ICC)
Secondary outcome measures include test-retest reliability (intraclass correlation coefficients, ICC), to verify the reproducibility of the measurements.
Time frame
Through study completion, an average of 1 year.2
Diagnostic performance
ROC analysis will be used to establish optimal cut-off points for clinical decision-making and to quantify the diagnostic performance of the test.
Time frame
Through study completion, an average of 1 year.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Semmelweis University
Lead sponsor
Budapest University of Technology and Economics
Collaborator
Source ClinicalTrials.gov